{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T16:21:37Z","timestamp":1707150097804},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.3816\/clm.2008.n.030","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T01:10:02Z","timestamp":1220490602000},"page":"230-236","source":"Crossref","is-referenced-by-count":14,"title":["The Hemostatic System and Malignancy"],"prefix":"10.3816","volume":"8","author":[{"given":"Dorothy M.","family":"Adcock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Marlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Zangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.030_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.030_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1055\/s-2007-1002580","article-title":"Tumor cell procoagulants and their role in malignant disease","volume":"18","author":"Gordon","year":"1992","journal-title":"Sem Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib3","first-page":"6229","article-title":"An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as new tumor marker","volume":"50","author":"Gordon","year":"1990","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(00)00691-4","article-title":"Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism","volume":"110","author":"Haim","year":"2001","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2008.n.030_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2005-863812","article-title":"Thrombophilia in cancer","volume":"31","author":"Falanga","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.3816\/CLM.2008.n.030_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1538-7836.2005.01606.x","article-title":"Decision analysis for cancer screening in idiopathic venous thromboembolism","volume":"3","author":"Di Nisio","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.3816\/CLM.2008.n.030_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1073274805012003S02","article-title":"Cancer and venous thromboembolism: scope of the problem","volume":"12","author":"Heit","year":"2005","journal-title":"Cancer Control"},{"key":"10.3816\/CLM.2008.n.030_bib8","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"New Engl J Med"},{"key":"10.3816\/CLM.2008.n.030_bib9","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1046\/j.1538-7836.2003.00490.x","article-title":"Screening for occult cancer in patients with idiopathic venous thromboembolism","volume":"1","author":"Lee","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-0037-1613296","article-title":"Coagulation markers predict survival in cancer patients","volume":"88","author":"Beer","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/j.1538-7836.2004.01011.x","article-title":"Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway","volume":"2","author":"Miller","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1538-7836.2005.01175.x","article-title":"The oral cancer model","volume":"3","author":"Sacks","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib13","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1074\/jbc.M007027200","article-title":"Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta5 Integrin","volume":"276","author":"Even-Ram","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3816\/CLM.2008.n.030_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(00)00112-4","article-title":"Signaling networks: the origins of cellular multitasking","volume":"103","author":"Jordan","year":"2000","journal-title":"Cell"},{"key":"10.3816\/CLM.2008.n.030_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.critrevonc.2007.01.001","article-title":"Cancer-associated thrombosis","volume":"62","author":"Zwicker","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl","key":"10.3816\/CLM.2008.n.030_bib16","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1378\/chest.124.3_suppl.58S","article-title":"Tissue factor, thrombin and cancer","volume":"124","author":"Rickles","year":"2003","journal-title":"Chest"},{"key":"10.3816\/CLM.2008.n.030_bib17","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1158\/0008-5472.CAN-06-1803","article-title":"Activation of cancer cells migration and invasion by ectopic synthesis of coagulation factor VII","volume":"66","author":"Koizume","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E","article-title":"Immunohistochemical identification of tissue factor in solid tumors","volume":"70","author":"Callander","year":"1992","journal-title":"Cancer"},{"key":"10.3816\/CLM.2008.n.030_bib19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/0008-5472.CAN-04-3376","article-title":"PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma","volume":"65","author":"Rong","year":"2005","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2004-822969","article-title":"Tissue factor and fibrin in tumor angiogenesis","volume":"30","author":"Fernandez","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.3816\/CLM.2008.n.030_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00062752-200209000-00003","article-title":"Tissue factor and angiogenesis in cancer","volume":"9","author":"Fernandez","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.3816\/CLM.2008.n.030_bib22","first-page":"9325","article-title":"Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor","volume":"95","author":"Abe","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2008.n.030_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","article-title":"Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype","volume":"10","author":"Nierodzik","year":"2006","journal-title":"Cancer Cell"},{"key":"10.3816\/CLM.2008.n.030_bib24","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1158\/0008-5472.CAN-05-2733","article-title":"A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment","volume":"65","author":"El-Sheikh","year":"2005","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib25","doi-asserted-by":"crossref","first-page":"30439","DOI":"10.1074\/jbc.M605440200","article-title":"Pro-urokinase-type plasminogen activator is a substrate for Hepsin","volume":"281","author":"Moran","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3816\/CLM.2008.n.030_bib26","doi-asserted-by":"crossref","first-page":"10643","DOI":"10.1158\/0008-5472.CAN-06-2350","article-title":"Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans","volume":"66","author":"Rak","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib27","first-page":"623","article-title":"Mechanism of tumor cell-induced extracellular matrix degradation\u2013inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis [in Japanese]","volume":"48","author":"Kobayashi","year":"1996","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.3816\/CLM.2008.n.030_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1160\/TH05-01-0054","article-title":"Plasminogen activation and cancer","volume":"93","author":"Dano","year":"2005","journal-title":"Throm Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib29","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1016\/j.ejca.2005.09.002","article-title":"Prognostic relevance of uPARdel4\/5 and TIMP-3 mRNA expression levels in breast cancer","volume":"41","author":"Kotzsch","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2008.n.030_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.2006.05.6853","article-title":"Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis","volume":"25","author":"Shariat","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.030_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bjoms.2005.10.009","article-title":"Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma","volume":"44","author":"Wang","year":"2006","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.030_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03357","article-title":"The MET oncogene drives a genetic programme linking cancer to haemostasis","volume":"434","author":"Boccaccio","year":"2005","journal-title":"Nature"},{"key":"10.3816\/CLM.2008.n.030_bib33","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2004-05-2042","article-title":"Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.030_bib34","first-page":"6966","article-title":"Spontaneous hematogenous and lymphatic metastasis, but no primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice","volume":"62","author":"Palumbo","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.2006.06208.x","article-title":"Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism","volume":"134","author":"Elice","year":"2006","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.030_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.10-1-72","article-title":"Warfarin versus low-molecularweight-heparin therapy in cancer patients","volume":"10","author":"Zacharski","year":"2005","journal-title":"Oncologist"},{"key":"10.3816\/CLM.2008.n.030_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E","article-title":"Subcutaneous heparin treatment increases survival in small cell lung cancer. \u201cPetites Cellules\u201d group","volume":"74","author":"Lebeau","year":"1994","journal-title":"Cancer"},{"key":"10.3816\/CLM.2008.n.030_bib38","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0037-1616771","article-title":"The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis","volume":"86","author":"Smorenburg","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(97)89484-3","article-title":"Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis","volume":"100","author":"Siragusa","year":"1996","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2008.n.030_bib40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib41","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","article-title":"Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer; the Fragmin Advanced Malignancy Outcome Study (FAMOUS)","volume":"22","author":"Kakkar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.030_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.n.030_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002689900081","article-title":"Comparison of low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial","volume":"20","author":"Meyer","year":"1996","journal-title":"World J Surg"},{"key":"10.3816\/CLM.2008.n.030_bib44","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.030_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2008.n.030_bib46","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1158\/1078-0432.CCR-05-0452","article-title":"Heparin octasaccharides inhibit angiogenesis in vivo","volume":"11","author":"Hasan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib47","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-05-1131","article-title":"Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selection inhibition, not antithrombotic activity","volume":"11","author":"Stevenson","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.6192498","article-title":"Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone","volume":"221","author":"Folkman","year":"1983","journal-title":"Science"},{"key":"10.3816\/CLM.2008.n.030_bib49","first-page":"6196","article-title":"Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis","volume":"60","author":"Collen","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.030_bib50","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1046\/j.1538-7836.2003.00341.x","article-title":"Antimetastatic effect of tinzaparin, a low-molecular-weight heparin","volume":"1","author":"Amirkhosravi","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.3816\/CLM.2008.n.030_bib51","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1245\/ASO.2006.05.018","article-title":"High Serum concentrations of Sialyl Lewis(x) predict multilevel N2 disease in non-small-cell lung cancer","volume":"13","author":"Mizuguchi","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.3816\/CLM.2008.n.030_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb Res"},{"key":"10.3816\/CLM.2008.n.030_bib53","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1200\/JCO.2005.81.908","article-title":"Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan-and bevacizumabbased therapy","volume":"23","author":"Shah","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.030_bib54","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","article-title":"Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy","volume":"98","author":"Zangari","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.030_bib55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djj189","article-title":"Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 93353 patients","volume":"98","author":"Bohlius","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2008.n.030_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","article-title":"Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells","volume":"92","author":"Falanga","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.030_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/14737140.7.3.307","article-title":"Thrombosis in multiple myeloma","volume":"7","author":"Zangari","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.3816\/CLM.2008.n.030_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.10454","article-title":"Prothrombotic coagulation abnormalities in patient with newly diagnosed multiple myeloma","volume":"92","author":"Auwerda","year":"2007","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2008.n.030_bib59","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1182\/blood-2006-12-038968","article-title":"How I treat patients with polycythemia vera","volume":"109","author":"Finazzi","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.030_bib60","first-page":"341","article-title":"Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom","volume":"29","author":"Tallman","year":"2005","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2008.n.030_bib61","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH05-04-0249","article-title":"Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity","volume":"95","author":"Banke","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T03:10:45Z","timestamp":1588907445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1557919011702360"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.030","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}